Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPY2R | P49146 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115791 | 0.79 | ESR1 (0.71) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL95882 | 0.77 | CA2 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| Benzene SCHEMBL28274900 | 0.77 | CA2 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL28809780 | 0.77 | CA2 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL31247 | 0.77 | ESR1 (0.54) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL25435946 | 0.77 | ESR1 (0.68) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL28225406 | 0.77 | ESR1 (0.42) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL140712 | 0.77 | CA2 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL10703445 | 0.76 | HPGD (0.64) | ALDH1A1GAAMAPTTDP1HTT | |
| SCHEMBL28448983 | 0.74 | ESR1 (0.52) | ESR1CA2CA4CA5AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591347-B | Moxidectin intermediate and preparation method thereof, and preparation method of moxidectin | 河北美荷药业有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-114591347-A | Moxidectin intermediate and preparation method thereof, and preparation method of moxidectin | 河北美荷药业有限公司 | 2022-06-07 | — | — | CN | claimed |
| EP-3647315-B9 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | VIVAVISION BIOTECH LTD (CN) | 2025-06-04 | — | — | EP | disclosed |
| EP-3647315-B1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | VIVAVISION BIOTECH LTD (CN) | 2024-11-20 | — | — | EP | disclosed |
| CN-114591347-B | Moxidectin intermediate and preparation method thereof, and preparation method of moxidectin | 河北美荷药业有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-114591347-A | Moxidectin intermediate and preparation method thereof, and preparation method of moxidectin | 河北美荷药业有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11325929-B2 | Phosphorus-containing compound and preparation and use thereof | VIVAVISIONSHANGHAILTD (CN) | 2022-05-10 | — | — | US | disclosed |
| US-11325929-B2 | Phosphorus-containing compound and preparation and use thereof | VIVAVISIONSHANGHAILTD (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-109134533-B | Phosphorus-containing compound and preparation and application thereof | 维眸生物科技（上海）有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-3647315-A1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | Vivavisionshanghailtd (CN) | 2020-05-06 | — | — | EP | disclosed |
| EP-3647315-A1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | Vivavisionshanghailtd (CN) | 2020-05-06 | — | — | EP | disclosed |
| US-4294989-A | OPTICALLY ACTIVE HYDROGENATION CATALYSTS | MONSANTO COMPANY (US) | 1981-10-13 | — | — | US | disclosed |
| US-4265827-A | METHYLCYCOHEXYL-O-ANISYLARSINE OPTICALLY ACTIVE CATALYST | MONSANTO COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4261919-A | OF BETA-SUBSTITUTED-ALPHA-ACYLAMIDO-ACRYLIC ACIDS TO YIELD OPTICALLY ACTIVE MIXTURE | MONSANTO COMPANY (US) | 1981-04-14 | — | — | US | disclosed |
| US-4212757-A | Peroxygen bleaching and compositions therefor | FMC CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4168267-A | Phosphinylalkanoyl prolines | E. R. SQUIBB & SONS, INC. (US) | 1979-09-18 | — | — | US | disclosed |
| US-4124533-A | HYDROGENATION CATALYSTS | MONSANTO COMPANY (US) | 1978-11-07 | — | — | US | disclosed |
| US-4113680-A | Method for preparing 17 α-ester-21-halo pregnanes | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-4005127-A | L-Dopa process and intermediates | MONSANTO COMPANY (US) | 1977-01-25 | — | — | US | disclosed |
| US-3957771-A | PHOSPHINIC ACID CHLORIDES, ALCOHOLS, HYDROLYSIS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325929-B2 | Phosphorus-containing compound and preparation and use thereof | INPP5D, CXCL12, INPPL1 | ESR1 2865/4885CA2 136/4885CA4 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.